APOA1 and metabolic dysfunction-associated steatotic liver disease: The study highlights the need for long-term prospective studies of apoA1 in HDL that contain or lack apoC3 and liver fat content, followed by assessing the relevance of these HDL subspecies as targets for the primary prevention of NAFLD.